A new animal sedative known as “rhino tranq” is showing up in the illegal fentanyl supply across the United States, and it is making opioid overdoses harder to reverse and withdrawal more dangerous than ever. For anyone struggling with narcotic addiction or opioid abuse, this threat demands urgent attention. The CDC, alongside the White House …
“Rhino Tranq” in the Fentanyl Supply Raises Overdose Risk

A new animal sedative known as “rhino tranq” is showing up in the illegal fentanyl supply across the United States, and it is making opioid overdoses harder to reverse and withdrawal more dangerous than ever.
For anyone struggling with narcotic addiction or opioid abuse, this threat demands urgent attention. The CDC, alongside the White House Office of National Drug Control Policy, issued a Health Advisory on April 2, 2026.
They warned public health professionals, clinicians and people at risk for overdose about rising reports of medetomidine, known on the street as “rhino tranq,” “mede,” or “dex”, appearing in the illegal drug supply. The drug is not approved for human use; it is approved for sedation in dogs.
Rhino Tranq Is Spreading Fast Through the Fentanyl Supply
The number of medetomidine detections reported to the National Forensic Laboratory Information System jumped 950% from 247 in 2023 to 2,616 in 2024, followed by a further 215% increase to 8,233 in 2025.
That is an explosive trajectory for a drug most people, including many clinicians, have never heard of. The geographic spread appears to be concentrated in the Northeast (52%) and Midwest (31%), followed by the South (17%) and the West (under 1%).
But fentanyl does not stay put, and neither does what gets mixed into it. Among drug product samples that tested positive for medetomidine between July and December 2025, 98% also had fentanyl co-detected.
It confirms that rhino tranq is being deliberately blended into what is sold as fentanyl. People using street opioids have no way of knowing it is there.
Why This Makes Fentanyl Even More Dangerous
Fentanyl is already the leading driver of overdose deaths in the United States. Adding medetomidine to the mix creates two new, compounding dangers: a harder-to-reverse overdose and a potentially life-threatening withdrawal syndrome.
Medetomidine can cause profound sedation, severe slowing of the heart rate, and dangerously low blood pressure. Stopping the drug after regular use can trigger severe withdrawal, similar to clonidine withdrawal.
Symptoms include high blood pressure, anxiety, nausea, vomiting, and fluctuating alertness that may require emergency or intensive care.
A May 2024 overdose cluster in Chicago linked to medetomidine involved 12 confirmed, 26 probable, and 140 suspected overdoses. Fentanyl was detected in all medetomidine-positive samples. At least 16 people were hospitalized and one person died.
Naloxone Is Still Essential But Has Limits
Naloxone (Narcan) remains the first-line response to any suspected opioid overdose, and that does not change with medetomidine in the picture.
Because fentanyl is involved in nearly all medetomidine-associated overdoses, opioid overdose reversal medications like naloxone should be administered in suspected overdoses to restore normal breathing.
However, naloxone can reverse the opioid component and restore breathing, but it will not reverse medetomidine’s sedating effects, meaning a person may still remain deeply unconscious even after naloxone is given.
The CDC recommends repeating naloxone every 2–3 minutes as needed to keep the person breathing at least once every 5 seconds, and placing the person in the recovery position with the airway clear. Call 911 immediately after administering naloxone.
What Rhino Tranq Withdrawal Looks Like
Medetomidine withdrawal symptoms can include rapid heart rate, severe high blood pressure, fluctuating alertness, tremor, chest pain, and intractable nausea and vomiting. Symptoms may begin within hours of last use and peak 18–36 hours later.
Serious complications including heart attack and a brain condition called posterior reversible encephalopathy syndrome have been associated with severe medetomidine withdrawal.
If you or someone you know is experiencing these symptoms after stopping opioid use, go to an emergency room immediately or call 911. This is not a withdrawal that can safely be managed at home.
Understanding Opioid Addiction and Narcotic Dependence
Opioids, including fentanyl, heroin and prescription painkillers, are highly addictive substances that create physical dependence rapidly. Fentanyl is 50 to 100 times more potent than morphine, which is why even a tiny amount of it can be lethal.
Narcotic addiction changes brain chemistry in ways that make stopping without support extremely difficult and, as this new data shows, physically dangerous.
Naloxone can reverse an overdose in the moment, but medication-assisted treatment and peer recovery are what sustain long-term survival.
Finding Help for Opioid Addiction
If you or someone you love is struggling with fentanyl, heroin addiction, or opioid abuse, help is available right now. Explore Narcotics.com’s directory to find NA meetings near you. You can also call 800-934-1582(Sponsored) to learn more about your treatment options.
the Take-Away